ClinVar Genomic variation as it relates to human health
NM_001844.5(COL2A1):c.823C>T (p.Arg275Cys)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001844.5(COL2A1):c.823C>T (p.Arg275Cys)
Variation ID: 17368 Accession: VCV000017368.37
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 12q13.11 12: 47994041 (GRCh38) [ NCBI UCSC ] 12: 48387824 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 4, 2013 May 12, 2024 Oct 24, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001844.5:c.823C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001835.3:p.Arg275Cys missense NM_033150.3:c.616C>T NP_149162.2:p.Arg206Cys missense NC_000012.12:g.47994041G>A NC_000012.11:g.48387824G>A NG_008072.1:g.15462C>T P02458:p.Arg275Cys - Protein change
- R206C, R275C
- Other names
-
R75C
- Canonical SPDI
- NC_000012.12:47994040:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
COL2A1 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
2872 | 2884 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (2) |
criteria provided, single submitter
|
Sep 22, 2022 | RCV000018912.35 | |
Pathogenic (1) |
criteria provided, single submitter
|
May 28, 2019 | RCV000988828.3 | |
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Oct 24, 2023 | RCV001385337.12 | |
Pathogenic (1) |
criteria provided, single submitter
|
- | RCV003228897.3 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jul 20, 2023 | RCV003323361.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(May 28, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Stickler syndrome type 1
Affected status: unknown
Allele origin:
unknown
|
Mendelics
Accession: SCV001138713.1
First in ClinVar: Jan 13, 2020 Last updated: Jan 13, 2020 |
|
|
Pathogenic
(Sep 22, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Spondyloepiphyseal dysplasia with metatarsal shortening
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin
Additional submitter:
CUBI - Core Unit Bioinformatics, Berlin Institute of Health
Accession: SCV002574833.1
First in ClinVar: Sep 24, 2022 Last updated: Sep 24, 2022 |
Clinical Features:
Premature osteoarthritis (present) , Hearing impairment (present)
Sex: male
Tissue: Blood
|
|
Pathogenic
(Jan 12, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV001814714.3
First in ClinVar: Sep 08, 2021 Last updated: Mar 04, 2023 |
Comment:
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; … (more)
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Reported in ClinVar but additional evidence is not available (ClinVar Variant ID 17368); This variant is associated with the following publications: (PMID: 21990059, 31633310, 31894489, 7757086, 16755660, 23928235, 23448908, 17726487, 31711313, 26183434, 15593085, 32071555, 31758797, 27234559, 28334714, 21204228, 26443184, 8877930, 26691295, 27523816, 16155195, 22791362, 21438135, 29738498, 25735649, 19433093, 21356074, 21472893, 18553548, 19764028, 21332586, 18383211, 8244341, 7738948, 8024616, 33706891, 30363003) (less)
|
|
Pathogenic
(Jul 20, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Achondrogenesis type II
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV004029340.1
First in ClinVar: Aug 26, 2023 Last updated: Aug 26, 2023 |
Comment:
Variant summary: COL2A1 c.823C>T (p.Arg275Cys), also referred to by the legacy name Arg75Cys in the literature, results in a non-conservative amino acid change located in … (more)
Variant summary: COL2A1 c.823C>T (p.Arg275Cys), also referred to by the legacy name Arg75Cys in the literature, results in a non-conservative amino acid change located in the collagen triple helix repeat region of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 250954 control chromosomes (gnomAD). c.823C>T has been reported in the literature in multiple individuals affected with Czech Dysplasia from geographically distinct families where it has been found to segregate with the disease phenotype in an autosomal dominant, fully penetrant pattern of inheritance (e.g. Carlson_2006, Tzschach_2008, Matsui_2009). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 16755660, 19764028, 18553548). Five submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. (less)
|
|
Pathogenic
(Nov 30, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Not provided
Affected status: yes
Allele origin:
germline
|
Blueprint Genetics
Accession: SCV001832467.1
First in ClinVar: Sep 08, 2021 Last updated: Sep 08, 2021
Comment:
Patient analyzed with Comprehensive Skeletal Dysplasias and Disorders Panel
|
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: research
|
Acetabular dysplasia
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
inherited
|
Rheumatology and Immunology Department, Shandong Provincial Hospital Affiliated to Shandong First Medicial University
Accession: SCV002754582.1
First in ClinVar: May 27, 2023 Last updated: May 27, 2023 |
Clinical Features:
Synovial chondromatosis (present)
Sex: male
|
|
Pathogenic
(Oct 24, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001585157.4
First in ClinVar: May 10, 2021 Last updated: Feb 14, 2024 |
Comment:
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 275 of the COL2A1 protein … (more)
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 275 of the COL2A1 protein (p.Arg275Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant COL2A1-related conditions (PMID: 8244341, 32071555). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Arg75Cys. ClinVar contains an entry for this variant (Variation ID: 17368). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COL2A1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Oct 01, 2009)
|
no assertion criteria provided
Method: literature only
|
CZECH DYSPLASIA
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000039196.5
First in ClinVar: Apr 04, 2013 Last updated: May 12, 2024 |
Comment on evidence:
This mutation has also been designated arg275-to-cys (R275C) based on a different numbering system. In a family living in the Chiloe Islands, Chile, Williams et … (more)
This mutation has also been designated arg275-to-cys (R275C) based on a different numbering system. In a family living in the Chiloe Islands, Chile, Williams et al. (1993) demonstrated a heterozygous arg75-to-cys (R75C) mutation in the COL2A1 gene as the basis of spondyloepiphyseal dysplasia with shortened metacarpals and metatarsals, precocious osteoarthritis, and periarticular apatite-like calcific deposits. Seven individuals were involved in 3 generations of the family. Complete physical examination, anthropometric measurements, and radiographic studies of the spine and peripheral joints in 16 family members revealed that 7 had spondyloepiphyseal dysplasia tarda, brachydactyly, precocious osteoarthritis, and periarticular calcification, while 2 others had the same syndrome without brachydactyly (Reginato et al., 1994). The relationship of this type of SEDT to familial calcium pyrophosphate dihydrate deposition disease (118600) and idiopathic hip dysplasia, both endemic in Chiloe Islanders, required further investigation. Hoornaert et al. (2007) performed targeted sequencing of exon 13 of the COL2A1 gene in patients with Czech dysplasia (609162) because of phenotypic similarities between individuals with this dysplasia and patients with the R75C mutation. They identified heterozygosity for the R75C mutation in 5 patients with Czech dysplasia, including 2 of the 4 original patients described with this disorder. All affected individuals had normal height, spondyloarthropathy, and short postaxial toes. In an affected father, daughter, and son from a Japanese family with Czech dysplasia, Matsui et al. (2009) identified heterozygosity for the R275C mutation in the COL2A1 gene. The mutation was not found in the unaffected mother. The authors stated that this was the first reported family with Czech dysplasia that was not of European ancestry, and family history was consistent with de novo occurrence of the disease in the father. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Clinical and Molecular Characterization and Discovery of Novel Genetic Mutations of Chinese Patients with COL2A1-related Dysplasia. | Xu Y | International journal of biological sciences | 2020 | PMID: 32071555 |
Czech dysplasia occurring in a Japanese family. | Matsui Y | American journal of medical genetics. Part A | 2009 | PMID: 19764028 |
Czech dysplasia: report of a large family and further delineation of the phenotype. | Tzschach A | American journal of medical genetics. Part A | 2008 | PMID: 18553548 |
Czech dysplasia metatarsal type: another type II collagen disorder. | Hoornaert KP | European journal of human genetics : EJHG | 2007 | PMID: 17726487 |
Precocious osteoarthritis in a family with recurrent COL2A1 mutation. | Carlson KM | The Journal of rheumatology | 2006 | PMID: 16755660 |
Familial spondyloepiphyseal dysplasia tarda, brachydactyly, and precocious osteoarthritis associated with an arginine 75-->cysteine mutation in the procollagen type II gene in a kindred of Chiloe Islanders. I. Clinical, radiographic, and pathologic findings. | Reginato AJ | Arthritis and rheumatism | 1994 | PMID: 8024616 |
Spondyloepiphyseal dysplasia and precocious osteoarthritis in a family with an Arg75-->Cys mutation in the procollagen type II gene (COL2A1). | Williams CJ | Human genetics | 1993 | PMID: 8244341 |
Text-mined citations for rs121912876 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.